Vera Byers | Academic Influence

Vera Byers's AcademicInfluence.com Rankings

Vera Byers

Biology

#15440

World Rank

#19417

Historical Rank

#3033

USA Rank

Immunology

#1077

World Rank

#1103

Historical Rank

#114

USA Rank

biology Degrees

Download Badge

Biology

Vera Byers's Degrees

Bachelors Biology University of California, Berkeley
PhD Immunology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Vera Byers Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Vera Steinberger Byers is an American immunologist who currently practices as a consultant in Incline Village, Nevada and was formerly a professor at the University of California San Francisco, before changing affiliations to University of Nottingham, where she helped conduct research on tumor immunology, later moving on to immunodermatology. While at UCSF, she helped develop a monoclonal antibody for use as an anticancer treatment, specifically against osteogenic sarcoma, though it was originally used against graft-versus-host disease. While at the University of Nottingham, she published some papers on the regulation of the immune response to urushiol in poison ivy/poison oak, also using a monoclonal antibody. Her work as a medical toxicologist pertaining to trichloroethylene features in the book A Civil Action. According to her testimony in the autism omnibus trial, she spent three years working at Immunex, where she worked on the anti-arthritis drug Enbrel. However, the special master in these proceedings wrote, "...there was no record at the FDA of Dr. Byers playing in any role in the Enbrel licensing application," to which Byers responded that "the information did not make a difference." The special master also wrote, "[Byers'] insistence that it was acceptable to use adult norms to measure the immune function of infants and young children was, frankly, incredible. Her testimony in this trial pertained to the alleged mechanism by which the measles virus from the MMR vaccine, in combination with thimerosal, caused Michelle Cedillo to suffer from a "dysregulated immune system." Dr. Byers formerly served on the editorial board of the journal Cancer Immunology, Immunotherapy, and has published some research in this journal.

(See a Problem?)

Vera Byers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Monoclonal antibodies for cancer detection and therapy (1985) (202)
Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line. (1981) (145)
Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis (2012) (122)
Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. (1975) (109)
A phase I/II study of trichosanthin treatment of HIV disease. (1990) (106)
Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. (1989) (104)
Randomised clinical trial: herbal extract HMPL‐004 in active ulcerative colitis – a double‐blind comparison with sustained release mesalazine (2011) (103)
Copper and zinc levels in serum from human patients with sarcomas (1976) (94)
Therapeutic strategies with monoclonal antibodies and immunoconjugates. (1988) (83)
A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents. (1994) (79)
Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia (2004) (74)
Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors. (1977) (73)
The X-Y-Z scheme of immunocyte maturation. 3. Early IgM memory and the nature of the memory cell. (1967) (66)
The Therapeutic Uses of Transfer Factor (1974) (61)
Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation. (1981) (57)
Environmental illness: a disorder of immune regulation. (1987) (48)
Tumor-specific cell-mediated immunity in household contacts of cancer patients.. (1975) (46)
Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma. (1975) (40)
Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients. (1989) (39)
Induction of antigen specific hyposensitization to poison oak in sensitized adults. (1982) (37)
Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines. (1986) (37)
Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. (1987) (34)
MONOCLONAL ANTIBODIES IN CANCER TREATMENT (1986) (30)
Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates. (1987) (30)
THE X-Y-Z SCHEME OF IMMUNOCYTE MATURATION (1968) (29)
In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response. (1979) (27)
Contact sensitivity to urushiol: role of covalent bond formation. (1982) (26)
INDUCTION AND REVERSAL OF IMMUNE PARALYSIS IN VITRO (1970) (26)
Circulating immune complexes in patients with bone tumours (1980) (26)
In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol. (1979) (25)
Standardization of tissue culture conditions for spontaneous thymidine-2-14C incorporation by unstimulated normal human peripheral lymphocytes: circadian rhythm of DNA synthesis. (1975) (24)
Induction of persistent tolerance to urushiol in humans. (1981) (24)
Circadian rhythm of stimulated lymphocyte blastogenesis. A 24 hour cycle in the mixed leukocyte culture reaction and with SKSD stimulation. (1976) (22)
Neurological reactions in HIV‐infected patients treated with trichosanthin (1993) (21)
Multiple Chemical Sensitivities: A Practicing Clinician's Point of View Clinical and Immunologic Research Findings (1992) (19)
THE X-Y-Z SCHEME OF IMMUNOCYTE MATURATION (1968) (19)
Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. (1991) (18)
A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts. (1989) (17)
Influence of chemical reactivity of urushiol-type haptens on sensitization and the induction of tolerance. (1986) (14)
Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol. (1986) (14)
Monoclonal antibodies and immunoconjugates for cancer treatment. (1987) (13)
A murine model system for contact sensitization to poison oak or ivy urushiol components. (1982) (12)
Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA (2004) (11)
Suppression of urushiol-induced delayed-type hypersensitivity responses in mice with serum IgG immunoglobulin from human hyposensitized donors. (1990) (11)
Regulation of murine contact sensitivity to urushiol components by serum factors. (1987) (9)
Monoclonal antibody drug targeting (1987) (9)
Targeted kill: From umbrellas to monoclonal antibodies (1992) (8)
Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor). (1979) (8)
Monoclonal Antibody Targeting of Cytotoxic Agents for Cancer Therapy (1987) (8)
Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies. (1981) (7)
Cellular interactions modulating host resistance to tumours. (1982) (7)
Monoclonal antibody immunoconjugates for cancer treatment. (1989) (6)
Immunoregulation by bacterial organisms and their role in the immunotherapy of cancer (1979) (6)
Immunotherapy of osteogenic sarcoma with transfer factor (1979) (6)
Immunology of Malignant Diseases (1987) (6)
Measles virus infection and vaccination: potential role in chronic illness and associated adverse events. (2004) (5)
Case Report: Autoimmune Disease Triggered by Exposure to Hair Straightening Treatment Containing Formaldehyde (2013) (5)
847x Double Blind Placebo Controlled Phase IIB Trial of HMPL-004 (Andrographis Paniculata Extract) in Active Mild to Moderate Ulcerative Colitis (UC) (2010) (5)
REGIOSPECIFIC ATTACK OF NITROGEN AND SULFUR NUCLEOPHILES ON QUINONES DERIVED FROM POISON OAK/IVY CATECHOLS (URUSHIOLS) AND ANALOGS AS MODELS FOR URUSHIOL-PROTEIN CONJUGATE FORMATION (1981) (5)
Monoclonal Antibodies and Immunoconjugates (1990) (5)
RNA‐ANTIGEN COMPLEXES: MECHANISM OF FORMATION AND THE TESTING OF A POSTULATED MODE OF ACTION * (1973) (4)
An Unusual Metastatic Lesion in a Patient with Osteosarcoma Receiving Tumor Specific Transfer Factor (1976) (4)
Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991 (1999) (4)
Induction of suppressor T cells for lymph node cell proliferation after contact sensitization of mice with a poison oak urushiol component. (1984) (4)
Monoclonal Antibodies for Drug Targeting in Cancer Therapy (1988) (4)
Randomized, Double-blind, Placebo-Controlled Trial of Andrographis Paniculata Extract (HMPL-004) in Patients with Moderately Active Crohnʼs Disease: 1180 (2010) (3)
Monoclonal antibody targeting of anti-cancer agents (2004) (3)
Rationale for clinical use of immunotoxins in cancer and autoimmune disease. (1991) (2)
Transfer factor therapy in osteogenic sarcoma. (1974) (2)
Viral Etiology of Human Osteosarcoma: Evidence Based on Response to Tumor-Specific Transfer Factor and on Immunoepidemiologic Studies (1975) (2)
Monoclonal antibodies: new agents for cancer detection and targeted therapy. (1991) (2)
132. E rosette formation in skin test-reactive asthmatic patients skin test-nonreactive asthmatic patients, and normal control subjects (1978) (2)
Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody. (1986) (1)
Ozone-friendly chemicals. (1994) (1)
Antibodies against osteosarcoma and colon cancer. (1984) (1)
Monoclonal antibody 791t 36 ricin a chain immunotoxin in the treatment of colorectal cancer (1987) (1)
MODULATION OF TUMOR CELL MEMBRANES WITH LIPOPHILIC HAPTENS: AN APPROACH TO MODIFYING TUMOR IMMUNOGENICITY (1979) (1)
Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies (1993) (1)
Endocytosis of Immunotoxin-791 T / 36-RTA by Tumor Cells in Relation to Its Cytotoxic Action 1 (2006) (1)
Monoclonal antibodies in colorectal cancer diagnosis and therapy (1988) (1)
Anti-idiotype antibody induction of antitumor responses. (1989) (0)
T H E X-Y-Z SCHEME OF IMMUNOCYTE MATURATION V. PARALYSIS OF MEMORY CELLS (2003) (0)
Measurement of murine IgE antibody responses to dust mite allergens by in vitro assay. (1999) (0)
Correction: Potentiation of Anti-Carcinoembryonic Antigen Immunotoxin Cytotoxicity by Monoclonal Antibodies Reacting with Co-Expressed Carcinoembryonic Antigen Epitopes (1988) (0)
Monoclonal antibodies and immunoconjugates for cancer treatment. (1988) (0)
Monoclonal for cancer detection and therapy (1985) (0)
Regional immunotherapy of guinea pig line-10 hepatoma with chemical hypersensitizers (1980) (0)
Meeting abstractDemonstration of the potentiation of endocytosis of an anti-CEA antibody by a colon carcinoma cell line using anti-CEA/NCA antibodies (1987) (0)
Monoclonal Antibody Conjugates with Cytotoxic Agents for Cancer Therapy (1989) (0)
Monoclonal antibody 791T/36 immunoconjugates for cancer treatment. (1989) (0)
A method and composition for the modulation of the host immune response to allergens (1994) (0)
At the Interface of Statistics and Medicine: Conflicting Paradigms (1997) (0)
In memoriam: John Jacob “Jack” Marchalonis (1940–2007) (2007) (0)
Ricin A Chain — Monoclonal Antibody 791T/36 Immunotoxin for Treatment of Colorectal and Ovarian Cancer (1989) (0)
Reply to the comment on the interpretation of lymphocyte phenotyping (1992) (0)
Immunological Evidence for a Viral Etiology of Certain Human Malignant Tumors* *This work was supported by U. S. Public Health Service grants (HD-05894) and (AI-09145). (1975) (0)
Cytotoxicity against human tumor cells by mixed monoclonal antibody drug conjugates (1986) (0)
F.25. Hemophagocytic Lymphohistiocytosis Following Vaccination with MMR and DPT (2006) (0)
In Memoriam: John Jacob “Jack” Marchalonis (2007) (0)

This paper list is powered by the following services:

Other Resources About Vera Byers

en.wikipedia.org

What Schools Are Affiliated With Vera Byers?

Vera Byers is affiliated with the following schools: